- Home
- FNKO vs ZURA Comparison
FNKO vs ZURA Comparison
Compare FNKO & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNKO
- ZURA
- Stock Information
- Founded
- FNKO 2017
- ZURA 2022
- Country
- FNKO United States
- ZURA United States
- Employees
- FNKO N/A
- ZURA N/A
- Industry
- FNKO Recreational Games/Products/Toys
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FNKO Consumer Discretionary
- ZURA Health Care
- Exchange
- FNKO Nasdaq
- ZURA Nasdaq
- Market Cap
- FNKO 170.7M
- ZURA 137.2M
- IPO Year
- FNKO 2017
- ZURA N/A
- Fundamental
- Price
- FNKO $3.32
- ZURA $3.61
- Analyst Decision
- FNKO Buy
- ZURA Buy
- Analyst Count
- FNKO 4
- ZURA 9
- Target Price
- FNKO $7.13
- ZURA $11.00
- AVG Volume (30 Days)
- FNKO 852.6K
- ZURA 650.4K
- Earning Date
- FNKO 11-06-2025
- ZURA 11-07-2025
- Dividend Yield
- FNKO N/A
- ZURA N/A
- EPS Growth
- FNKO N/A
- ZURA N/A
- EPS
- FNKO N/A
- ZURA N/A
- Revenue
- FNKO $928,842,000.00
- ZURA N/A
- Revenue This Year
- FNKO N/A
- ZURA N/A
- Revenue Next Year
- FNKO $10.57
- ZURA N/A
- P/E Ratio
- FNKO N/A
- ZURA N/A
- Revenue Growth
- FNKO N/A
- ZURA N/A
- 52 Week Low
- FNKO $2.22
- ZURA $0.97
- 52 Week High
- FNKO $14.65
- ZURA $4.85
- Technical
- Relative Strength Index (RSI)
- FNKO 54.83
- ZURA 54.25
- Support Level
- FNKO $2.93
- ZURA $3.72
- Resistance Level
- FNKO $3.18
- ZURA $3.73
- Average True Range (ATR)
- FNKO 0.20
- ZURA 0.24
- MACD
- FNKO 0.03
- ZURA -0.07
- Stochastic Oscillator
- FNKO 47.76
- ZURA 44.33
About FNKO Funko Inc.
Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.